Differential activity of PARP inhibitors in BRCA1- Versus BRCA2-altered metastatic castration-resistant prostate cancer

Fadi Taza, Albert E. Holler, Wei Fu, Hao Wang, Nabil Adra, Costantine Albany, Ryan Ashkar, Heather H. Cheng, Alexandra O. Sokolova, Neeraj Agarwal, Adam Kessel, Alan Bryce, Nellie Nafissi, Pedro Barata, A. Oliver Sartor, Diogo Bastos, Oren Smaletz, Jacob E. Berchuck, Mary Ellen Taplin, Rahul AggarwalCora N. Sternberg, Panagiotis J. Vlachostergios, Ajjai S. Alva, Christopher Su, Catherine H. Marshall, Emmanuel S. Antonarakis

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Differential activity of PARP inhibitors in BRCA1- Versus BRCA2-altered metastatic castration-resistant prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences